In females, BRCA1 and BRCA2 alterations lead to a 72% and 69% cumulative lifetime risk of breast cancer, respectively [1], and a cumulative lifetime risk of ovarian cancer of 44% and 17%, respectively [1]. This evidence concerns the gene BRCA1 and ovarian cancer.